Guizhou Sanli Pharmaceutical Co Ltd (603439.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE1000040B4
Guizhou Sanli Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.14 bn CNY | 1.70 bn CNY |
| Gross profit | 1.49 bn CNY | 1.19 bn CNY |
| Operating income | 326.25 m CNY | 198.70 m CNY |
| EBIT | 339.67 m CNY | 78.84 m CNY |
| Net income | 274.03 m CNY | 46.25 m CNY |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Guizhou Sanli Pharmaceutical Co Ltd
Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonifying, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. In addition, the company trades medicinal herbs. Guizhou Sanli Pharmaceutical Co.,Ltd was founded in 1995 and is based in Anshun, China.
More stocks
- Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211.SZ)
- Eve Holding, Inc. (EVEX)
- Wiit SpA (WIIT.MI)
- Amtran Technology Co Ltd (2489.TW)
- Hyundai Energy Solutions Co Ltd (322000.KS)
- Pansoft Company Limited (300996.SZ)
- Hollywood Bowl Group PLC (BOWL.L)
- Genda Inc (9166.T)
- WORLD ACCEPTANCE CORP (WRLD)
- Klaveness Combination Carriers ASA (KCC.OL)
- Beijing Thunisoft Co Ltd (300271.SZ)
- Guangzhou Boji Medical and Biotechnological Co Ltd (300404.SZ)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.